Louise A Jackett

Credit Name
Louise A Jackett
Full Name
Jackett, Louise A
 
 
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Carlino, Matteo S

Results 1-4 of 4 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
1Feb-2022BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.Scolyer, Richard A; Atkinson, Victoria; Gyorki, David E; Lambie, Duncan; O'Toole, Sandra; Saw, Robyn P M; Amanuel, Benhur; Angel, Christopher M; Button-Sloan, Alison E; Carlino, Matteo S; Ch'ng, Sydney; Colebatch, Andrew J; Daneshvar, Dariush; Pires da Silva, InĂªs; Dawson, Tamara; Ferguson, Peter M; Foster-Smith, Erwin; Fox, Stephen B; Gill, Anthony J; Gupta, Ruta; Henderson, Michael A; Hong, Angela M; Howle, Julie R; Jackett, Louise A ; James, Craig; Lee, C Soon; Lochhead, Alistair; Loh, Daphne; McArthur, Grant A; McLean, Catriona A; Menzies, Alexander M; Nieweg, Omgo E; O'Brien, Blake H; Pennington, Thomas E; Potter, Alison J; Prakash, Saurabh; Rawson, Robert V; Read, Rebecca L; Rtshiladze, Michael A; Shannon, Kerwin F; Smithers, B Mark; Spillane, Andrew J; Stretch, Jonathan R; Thompson, John F; Tucker, Paul; Varey, Alexander H R; Vilain, Ricardo E; Wood, Benjamin A; Long, Georgina V
212-Apr-2021Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.Klein, Oliver ; Senko, Clare ; Carlino, Matteo S; Markman, Ben; Jackett, Louise A ; Gao, Bo; Lum, Caroline; Kee, Damien ; Behren, Andreas; Palmer, Jodie ; Cebon, Jonathan S 
31-Sep-2020Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial.Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Jackett, Louise A ; Lum, Caroline; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S 
4Sep-2020Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers.Klein, Oliver ; Kee, Damien ; Markman, Ben; Michael, Michael; Underhill, Craig; Carlino, Matteo S; Jackett, Louise A ; Lum, Caroline; Scott, Clare; Nagrial, Adnan; Behren, Andreas; So, Jane Y; Palmer, Jodie ; Cebon, Jonathan S